Font Size: a A A
Keyword [Chemotherapy in Breast Cancer]
Result: 21 - 40 | Page: 2 of 6
21. Expression Changes Of C-erbB-2, CXCR4 And ER-α After Neoadjuvant Chemotherapy In Breast Cancer And Their Significance
22. The Relationship Between The Expression Of CerbB-2, Ki-67,PARP-1before And After Neoadjuvant Chemotherapy In Breast Cancer And Response To Neoadjuvant Chemotherapy
23. Clinical Study Of Screening Sensitive Markers Of Chemotherapy In Breast Cancer
24. Three-dimentional Contrast Enhanced Ultrasound In The Diagnostic Strategy Of Tumor Angiogenesis And In The Evaluation Of Tumor Response To Neoadjuvant Chemotherapy In Breast Cancer
25. Exome Sequencing Identified Mutation Shift During Neoadjuvant Chemotherapy In Breast Cancer
26. Exploration Of Response-related Factors And Development Of Predictive Nomogram For Neoadjuvant Chemotherapy In Breast Cancer
27. Discordances In ER, PR, HER-2and Ki67after Neo-adjuvant Chemotherapy In Breast Cancer
28. The Forecast Value Of E-cadherin In Neoadjuvant Chemotherapy In Breast Cancer
29. The Relationship Between P-gp Expression And Neoadjuvant Chemotherapy In Breast Cancer
30. Significance Of Ki67Expression To Determine The Efficacy Of Neoadjuvant Chemotherapy In Breast Cancer
31. A Clinical Study On Effects Of Jianpiyishen Decoction On Reliving Bone Marrow Suppression Due To Chemotherapy In Breast Cancer Patients
32. The Application Of Contrast-enhanced Ultrasound For Evaluating The Response Of The Neoadjuvant Chemotherapy In Breast Cancer
33. Expression Of Immune Co-stimulatory Molecule B7-H1and The Effect Of Chemotherapy In Breast Cancer On It
34. Efficacy Of Vinorelbine-based Neoadjuvant Chemotherapy In Breast Cancer: A Meta-analysis Of Randomized Controlled Trials
35. Clinical Research Of Acute Gastrointestinal Side Effects Of Chemotherapy In Breast Cancer Treated By Bo’s Abdominal Acapuncture
36. Influence And Analysis In ER, PR, Her-2and Ki-67after Neoadjuvant Chemotherapy In Breast Cancer
37. Sentinel Node Biopsy After Neoadjuvant Chemotherapy In Breast Cancer Patients With Initial Clinical Positive Node:Systematic Review And Meta-analysis
38. To Investigate The Clinical Value Of Chemosensitivity Test For Neoadjuvant Chemotherapy In Breast Cancer
39. The Value Of S100A4in The Evaluation Of The Neoadjuvant Chemotherapy In Breast Cancer
40. The Influence And Clinical Significance Of ER PR Her-2 And Ki-67 Expression Before And After Neo-adjuvant Chemotherapy In Breast Cancer
  <<First  <Prev  Next>  Last>>  Jump to